ProfileGDS4718 / 202214_s_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 89% 91% 97% 91% 91% 92% 91% 90% 91% 90% 87% 90% 88% 95% 93% 90% 91% 93% 87% 91% 90% 91% 90% 89% 90% 93% 91% 96% 90% 93% 90% 94% 90% 89% 93% 96% 93% 90% 91% 97% 90% 92% 95% 93% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]9.0385789
GSM549102patient 115, normal, homogenized [OPG study]9.3679891
GSM549104patient 119, normal, homogenized [OPG study]11.05397
GSM549108patient 138, normal, homogenized [OPG study]9.3543291
GSM549119patient 077, normal, homogenized [OPG study]9.4017391
GSM549133patient 032, cancer, homogenized [OPG study]9.6629492
GSM549139patient 042, cancer, homogenized [OPG study]9.3658991
GSM549099patient 107, normal, homogenized [OPG study]9.1600490
GSM549109patient 139, normal, homogenized [OPG study]9.3962991
GSM549110patient 046, normal, homogenized [OPG study]9.2511390
GSM549114patient 063, normal, homogenized [OPG study]8.8761887
GSM549122patient 082, normal, homogenized [OPG study]9.2921990
GSM549134patient 033, cancer, homogenized [OPG study]8.8500488
GSM549136patient 036, cancer, homogenized [OPG study]10.209295
GSM549140patient 044, cancer, homogenized [OPG study]9.7060493
GSM549111patient 047, normal, homogenized [OPG study]9.3027190
GSM549113patient 057, normal, homogenized [OPG study]9.6256691
GSM549132patient 031, cancer, homogenized [OPG study]9.7177493
GSM549137patient 038, cancer, homogenized [OPG study]8.6999387
GSM549142patient 047, cancer, homogenized [OPG study]8.8172691
GSM549100patient 110, normal, homogenized [OPG study]9.1399690
GSM549107patient 135, normal, homogenized [OPG study]9.4361791
GSM549115patient 068, normal, homogenized [OPG study]9.3690590
GSM549116patient 072, normal, homogenized [OPG study]9.1622989
GSM549120patient 078, normal, homogenized [OPG study]9.3160190
GSM549131patient 030, cancer, homogenized [OPG study]9.7802493
GSM549118patient 074, normal, homogenized [OPG study]9.4727391
GSM549129patient 027, cancer, homogenized [OPG study]10.188696
GSM549123patient 088, normal, homogenized [OPG study]9.3161190
GSM549124patient 006, cancer, homogenized [OPG study]9.5829693
GSM549126patient 015, cancer, homogenized [OPG study]9.1963290
GSM549128patient 025, cancer, homogenized [OPG study]10.023294
GSM549103patient 117, normal, homogenized [OPG study]9.1444790
GSM549117patient 073, normal, homogenized [OPG study]9.2713189
GSM549138patient 041, cancer, homogenized [OPG study]9.6633893
GSM549141patient 045, cancer, homogenized [OPG study]10.659796
GSM549130patient 028, cancer, homogenized [OPG study]9.5566993
GSM549101patient 111, normal, homogenized [OPG study]9.2172490
GSM549105patient 128, normal, homogenized [OPG study]9.4226691
GSM549106patient 134, normal, homogenized [OPG study]10.940697
GSM549112patient 048, normal, homogenized [OPG study]9.3095790
GSM549125patient 011, cancer, homogenized [OPG study]9.4321392
GSM549127patient 024, cancer, homogenized [OPG study]10.039795
GSM549135patient 035, cancer, homogenized [OPG study]9.7772693